About 3,390 results
Open links in new tab
  1. Psychedelic and Dissociative Drugs - National Institute on Drug Abuse ...

    Aug 29, 2024 · Psychedelic and dissociative drugs can temporarily alter a person’s mood, thoughts, and perceptions. Among other health effects and safety concerns, people who use these substances …

  2. News Main Archives - NIDA IRP

    Understanding how psychedelics exert therapeutic effects without inducing hallucinogenic side effects is a key challenge in neuropsychiatric drug development. Muir et al. combine multiple cutting-edge …

  3. MDMA (Ecstasy/Molly) - National Institute on Drug Abuse (NIDA)

    Apr 19, 2024 · MDMA, also called Molly or Ecstasy, is a lab-made (synthetic) drug that has effects similar to stimulants like methamphetamine, although some researchers and organizations consider …

  4. Technology Resources Initiative Paper of the Month

    Technology Resource Initiative – Paper of the Month – August 2025 Isolation of psychedelic-responsive neurons underlying anxiolytic behavioral states. Published in Science. Understanding how …

  5. Psychedelic and Dissociative Drugs as Medicines

    Jan 24, 2024 · Are psychedelic or dissociative drugs already approved as medicines? Are psychedelic and dissociative drugs being studied as potential medical treatments? What is psychedelic-assisted …

  6. National Institute on Drug Abuse Intramural Research Program

    The National Institute on Drug Abuse Intramural Research Program is a research facility in Baltimore, MD. The NIDA IRP dedicated to understanding the causes, consequences and treatment of drug …

  7. News Main Archives - NIDA IRP

    Technology Resource Initiative – Paper of the Month – August 2025 Isolation of psychedelic-responsive neurons underlying anxiolytic behavioral states. Published in Science. Understanding how …

  8. Increasingly, psychedelic compounds are being investigated for the treatment of various neuropsychiatric disorders, including major depressive disorder (MDD). Unlike classic …

  9. In one such study, we showed that administration of a single dose of psychedelic DOI produces changes in chromatin organization in mouse frontal cortex, particularly at enhancer regions of genes involved …

  10. Innovation and Entrepreneurship NIDA provided early funding to startups tackling the overdose crisis in unique ways, such as by monitoring wastewater for patterns of drug use and providing SUD care by …